COLA Names Keynote Speakers for Laboratory Enrichment Forum
Industry leaders at COLA will share insights on advancements in lab science and crucial aspects of CLIA compliance and lab accreditation.
Read MorePosted by Andy Lundin | Jan 19, 2024 | Education |
Industry leaders at COLA will share insights on advancements in lab science and crucial aspects of CLIA compliance and lab accreditation.
Read MorePosted by Chris Wolski | Jan 17, 2024 | Respiratory Disease |
This FDA De Novo marketing authorization signifies the first ever FDA authorization of a diagnostic tool of any type in lung fibrosis.
Read MorePosted by Andy Lundin | Jan 16, 2024 | Melanoma, Molecular Diagnostics |
The molecular Skin Fluorescence Imaging System noninvasively identifies and assesses activity associated with melanoma development.
Read MorePosted by Andy Lundin | Jan 15, 2024 | Company News |
Veracyte will acquire C2i Genomics, a MRD detection company, adding whole-genome MRD capabilities to its diagnostics platform.
Read MorePosted by Chris Wolski | Jan 12, 2024 | Digital Pathology |
By examining the UK’s technology-centric strategy and response, nations can right-size the practice of pathology and prepare for the future.
Read More